Showing 721-740 of 753 for: Cochrane Systematic Reviews > Pharmacotherapeutics 
- Traditional corticosteroids for induction of remission in Crohn's disease
Cochrane Systematic Reviews, 28-Feb-2010
Historically, corticosteroids have been the most commonly used class of medication for induction of remission in Crohn's disease (CD). Corticosteroids down regulate production of inflammatory cytokines and interfere with NF-?B production, thereby blunting
- Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis
Cochrane Systematic Reviews, 19-Nov-2015
Pouchitis occurs in approximately 50% of patients following ileal pouch-anal anastomosis (IPAA) for chronic ulcerative colitis.
- Treatment for amphetamine dependence and abuse
Cochrane Systematic Reviews, 15-Apr-2014
Amphetamine use is of concern because it causes a variety of devastating health physical and neurological consequences, including amphetamine-induced mental disorders.
- Treatment for amphetamine psychosis
Cochrane Systematic Reviews, 19-Oct-2008
Chronic amphetamine users may have experience of paranoia and hallucination. It has long been believed that dopamine antagonists, such as chlorpromazine, haloperidol, and thioridazine, are effective for the treatment of amphetamine psychosis.
- Treatment for IgG and IgA paraproteinaemic neuropathy
Cochrane Systematic Reviews, 17-Mar-2015
Paraproteinaemic neuropathy refers to those neuropathies associated with a monoclonal gammopathy or paraprotein. The most common of these present with a chronic, predominantly sensory, symmetrical neuropathy, similar to chronic inflammatory demyelinating
- Treatment for Lambert-Eaton myasthenic syndrome
Cochrane Systematic Reviews, 16-Jan-2011
Lambert-Eaton myasthenic syndrome (LEMS) is an autoimmune disorder of neuromuscular transmission. Treatments attempt to overcome the harmful autoimmune process, or improve residual neuromuscular transmission
- Treatment for superficial thrombophlebitis of the leg
Cochrane Systematic Reviews, 25-Feb-2018
The optimal treatment of superficial thrombophlebitis (ST) of the legs remains poorly defined. While improving or relieving the local painful symptoms, treatment should aim at preventing venous thromboembolism (VTE), which might complicate the natural his
- Tricyclic and related drugs for nocturnal enuresis in children
Cochrane Systematic Reviews, 18-Jan-2016
Enuresis (bedwetting) affects up to 20% of five year-olds and 2% of adults. Although spontaneous remission often occurs, the social, emotional and psychological costs can be great. Tricyclics have been used to treat enuresis since the 1960s.
- Tricyclic drugs for depression in children and adolescents
Cochrane Systematic Reviews, 13-Jun-2013
There is a need to identify effective and safe treatments for depression in children and adolescents. While tricyclic drugs are effective in treating depression in adults, individual studies involving children and adolescents have been equivocal. Prescrib
- Trifluoperazine for schizophrenia
Cochrane Systematic Reviews, 13-Apr-2010
Trifluoperazine is an inexpensive accessible 'high potency' antipsychotic drug, widely used to treat schizophrenia or related psychoses.
- Troleandomycin as an oral corticosteroid sparing agent in stable asthma
Cochrane Systematic Reviews, 5-Oct-2010
Patients with chronic severe asthma are often dependent on the long term prescription of oral corticosteroids. The use of steroids is associated with serious side effects. Physicians treating such patients continue to search for alternative therapies that
- Unfractionated or low-molecular weight heparin for induction of remission in ulcerative colitis
Cochrane Systematic Reviews, 4-Aug-2015
There are a limited number of treatment options for patients with ulcerative colitis (UC). An increased risk of thrombosis in UC coupled with an observation that UC patients being treated with anticoagulant therapy for thrombotic events had an improvement
- Valproate for schizophrenia
Cochrane Systematic Reviews, 13-Apr-2010
Many people with schizophrenia do not achieve a satisfactory treatment response with ordinary antipsychotic drug treatment. In these cases, various add-on medications are used; valproate is one of these.
- Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder
Cochrane Systematic Reviews, 16-Oct-2013
Bipolar disorder is a recurrent illness that is amongst the top 30 causes of disability worldwide and is associated with significant healthcare costs. In the past, emphasis was placed solely on the treatment of acute episodes of bipolar disorder; recently
- Vancomycin for prophylaxis against sepsis in preterm neonates
Cochrane Systematic Reviews, 22-Oct-2008
Nosocomial, late onset, sepsis occurs in up to 50% of infants of less than 1000gm at birth. The most frequent organism isolated is coagulase negative staphylococcus (CoNS). A number of studies have evaluated the efficacy of prophylactic low dose vancomyci
- Vasoactive drugs for acute stroke
Cochrane Systematic Reviews, 3-Jun-2010
It is unclear whether blood pressure (BP) should be altered actively during the acute phase of stroke.
- Vasodilators and vasoactive substances for idiopathic sudden sensorineural hearing loss
Cochrane Systematic Reviews, 14-Feb-2010
Idiopathic sudden sensorineural hearing loss (ISSHL) is sudden hearing loss where clinical assessment fails to reveal a cause. The most widely used therapeutic agents for ISSHL are antivirals, steroids, hyperbaric oxygen, vasodilators and rheological/vaso
- Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men
Cochrane Systematic Reviews, 16-Feb-2016
Vitamin D and related compounds have been used to prevent osteoporotic fractures in older people. This is the third update of a Cochrane review first published in 1996.
- Vitamin E for Alzheimer's dementia and mild cognitive impairment
Cochrane Systematic Reviews, 12-Oct-2012
Vitamin E is a dietary compound that functions as an antioxidant scavenging toxic free radicals. Evidence that free radicals may contribute to the pathological processes of cognitive impairment including Alzheimer's disease has led to interest in the use
- Vitamin E for intermittent claudication
Cochrane Systematic Reviews, 16-Oct-2008
It is thought that vitamin E may improve tolerance to intermittent claudication (i.e. pain caused by ischaemia in the muscles of the leg during exercise), thereby relieving the pain, through a variety of mechanisms.
